Canadian Securities ExchangeThe Daily Bell

Nextleaf Solutions (CSE:OILS)

Cannabis CPG & Global Growth

August 24, 2026CSE Listed Issuer UpdatesCSE x Cultivated

Nextleaf Solutions Ltd. (CSE:OILS)

About This Video

On the latest Issuer Update as part of the CSE x Cultivated series, host Jay Rosenthal sits down with Emma Andrews, CEO of Nextleaf Solutions Ltd. (CSE:OILS), to discuss the company’s evolution from patented extraction technology to consumer packaged goods - and the growing international opportunity for its cannabis products.

Built on a portfolio of patented extraction processes, Nextleaf has expanded into branded consumer products through Glacial Gold and Yard while maintaining a disciplined, debt-free approach to growth. Today, consumer packaged goods have become a consistent revenue driver for the company, complemented by its bulk ingredient business.

**Spotlight: Taking a Canadian cannabis platform global**

Andrews discusses how Nextleaf accelerated its international strategy, including its first white-label shipment of nearly one million softgels to Australia and additional client contracts now underway in the market. With a scalable production platform and shelf-stable product formats, the company sees international exports as an increasingly important part of its growth strategy heading into fiscal 2027.

Also in this episode:

• How Nextleaf is commercializing its patent portfolio through branded products

• The evolution of Glacial Gold and the growing opportunity in wellness-focused cannabis formats

• Why CPG has become a key source of consistent revenue alongside bulk ingredients

• Expanding internationally through Australia and the global cannabis supply chain

• Industry advocacy and the push to reduce regulatory barriers for Canadian licensed producers

Watch the full conversation to learn how Nextleaf Solutions is positioning its technology, brands, and manufacturing capabilities for the next stage of the cannabis industry.

Subscribe for more great CSE insights and interviews here: https://go.thecse.com/CSETV-Subscribe

STAY CONNECTED WITH THE CSE

=============================

- NEWSLETTER: https://go.thecse.com/CSE-Mailing-List-Subscribe

- PODCAST: https://blog.thecse.com/cse-podcasts/

- INSTAGRAM: https://www.instagram.com/canadianexchange/

- LINKEDIN: https://ca.linkedin.com/company/canadian-securities-exchange

- FACEBOOK: https://www.facebook.com/CanadianSecuritiesExchange/

- TWITTER: https://twitter.com/CSE_News

- BLOG: https://blog.thecse.com/

- WEBSITE: https://thecse.com/

- MAGAZINE: https://issuu.com/thecse/docs

Read the TranscriptAuto-generated by YouTube; names and terms may be misspelled.

Welcome everybody for another episode of Cultivated at the Canadian Securities Exchange high atop the Toronto skyline. Today we are pleased to be joined by Emma Andrews. She is the CEO of Next Leaf Solutions. They trade under OILS on the Canadian Securities Exchange. We look forward to talking to her about where the company is today, what she sees in the Canadian market, international market, and maybe where they're going tomorrow as well. So

coming up, this is Emma Andrews, CEO of Next Leaf Solutions. Emma, thanks so much for being here. >> My pleasure. Thanks, Jay. It's nice to connect again. >> Nice to connect again. I think the last time was five, maybe six years ago. I was going to sort of say what's changed, but but truthfully, when when I first met the Next Leaf Solutions team and you, it was an extractions company. It was

based on IP and patents you guys had. And since then it's become let's say more robust, and you have brands in the field. Talk brands at all over the country and a variety of different SKUs. Talk a little bit about the impetus for that pivot way back when, and sort of give us a sort of touch point of where we are now. >> Yeah, you bet. And it's really just an

expansion story cuz the patents are still there. They're what fuels this entire vision because that's the process behind the products that we're seeing in market now. And for us in the early days of the industry and and the inception for Next Leaf, when we created those patents, we knew that was a longer-term strategy. There wasn't immediate revenue to be realized off those patents. That was still part of the strong hold that

we wanted to build, the moat of defensibility for our company. So now entering into consumer branded goods is the way of commercializing and validating our patents through branded products that are made from the process itself, and that's what is patented. So yeah, it's a really strong foundation and natural evolution for the company. We wanted to realize revenue, and that's what consumer packaged goods allows us to do. And particularly here in Canada,

we're dominant in soft gels, so it's been a good journey. >> Well, that's what I wanted to ask you about. Give us the lay of the land of the brands that are your brands, and maybe the footprints in which they operate, and I know you like talking about where they rank, and so talk about where they rank in different provinces and different product categories, cuz I think it's really instructive sort of

the foundation upon which Next Leaf built, and then the brands that are in in place now, and talk about sort of the scale and scope. >> I am incredibly proud of our build, truly. It's been a really humble and bootstrap build, and as a brand marketer, it creates a lot of challenges and constraints in how you build a brand when you are more limited on capital, and we are self-funded, right? We're a

debt-free LP, which is a rarity in this industry. So, every dollar earned is reinvested back into the business. So, for us, we launched into BC, which was our backyard, with Glacial Gold, a well-loved legacy brand that we brought into the legal market. We've done a few iterations, kind of revamping the look, the feel, and also the product assortment under Glacial Gold. When it was, you know, best loved in the

legacy era, it was known for shatter, which is so far from where we land now, which is architecting towards the wellness consumer. So, non-combustible products, things like soft gels, oils, and vapes as well. So, that's under Glacial Gold. This has become the national leader in wellness-forward formats, and that's something that over time evolved. We were really kind of, you know, testing what would work in the market, and being the fact that we can

own our own process, manufacture our own products, it allowed us a lot of agility in that commercial process and scaling up to the portfolio you see now. And when we started with soft gels, that was again a bit of a throw-it-at-the-wall, see what sticks, are consumers ready for this, is category evolution there, and it was. And so, soft gels started to become a mainstay in our portfolio. To

our advantage, we focus on niches that other brands look at as an afterthought. And so what's ended up becoming a big part of our portfolio is things like ratio vapes and balanced formulations, minor cannabinoids we're having a lot of success in. And so it's been identifying opportunities in the peripherals where it's often overlooked opportunity. And then we capitalize on that by focusing on it and really blowing it up. And so

something like the wellness opportunity some may think it's a lower total market size than THC dominant or flower forward formats. However, it's growing and that's where we see the opportunity is where is there continued growth as we continue to see the maturity in the industry domestically and abroad. So with Glacial Gold going harder into wellness forward consumers and formats, we've had the opportunity to launch a brand named Yard, which allows us to

speak a little bit more toward the recreational consumer. And that's a little bit more of our, you know, pre-roll, dabble, infused pre-rolls, vapes. So that's a bit more of your true recreational consumer. So the sophistication and the maturity that is natural in a CPG brand is, you know, speaking to different consumers with different brands. So that's where we are today. >> And I wonder you talked a little bit

about the business setup and the and the organizational structure and even where you came from. Like it seems to me that the maturation of the Canadian market plus or in addition to sort of the nimbleness in which you can operate because you own the sort of input or own the the ideas behind it. Like it makes you makes the ability for you to pivot and add SKUs and test things that others

may not be able to do. And you've evolved with the industry to understand that like day one there was no data about what consumers wanted. There was no market even sell it in. Now it's much more robust across the country. The consumer profile has changed pretty dramatically and there are still market opportunities that are on the upswing as opposed to sort of stabilize. And like it's sort of

a combination of more data, better data, the ability to pivot, the operational structure that you operate in. Like it's sort of a magic and unique mix in the landscape. Talk a little bit about that. Cuz some of it is great luck, and some of it is very intentional, but talk sort of talk about that magic mix. >> Yeah. Yeah, timing is everything in entrepreneurialism, and you interview lots of executives and and leaders in

the industry, and you probably hear that as a theme quite often. So, for us a lot of it is outwit outwit outlast outplay, kind of the survivor mentality, where you have to be a little bit bootstrapped to make sure that you have the reserves to last. And one of our vision or one of our values, I should say, sorry, is to build a sustainable legacy. So, our financial discipline is not only for

survivability today, it's also for sustainability into the future. So, yeah, we've seen the sophistication of categories mature, even a bit of category reform happening, subcategories starting to become more dominant, and it's not all about THC potency. And so, there's opportunities for more diversification in the product assortment to meet consumers where they're at. And that rolls up into more diversification off of retail banners as well. They have more of an opportunity to have a bespoke

or curated selection of products that might be more unique to their doors. So, we're really starting to cater, customize, and tailor for the consumer and their needs states more directly, everything from product assortment through to the retail experience. So, it's a nice level of sophistication the the Canadian industry is seeing. >> Well, I want to talk a bit about Canada in the grand scheme of sort of cannabis and cannabis products more

worldwide. The way cannabis has evolved is obviously a highly restrictive, regulated environment, and done it at scale across the country, which has positioned the country fairly well for what has emerged on the international market, whether it's Australia, many companies are doing business in Germany, and other markets are opening up. Talk a little bit about the position your company is in to be part of that, and sort of how investments made long ago

are paying off now sort of on the worldwide stage, and where you see that going if you see it going over the next sort of 12 24 months, because it seems to me that to me I'm biased, I live here, like Canada is actually better positioned to take advantage of international markets than our neighbors and cousins to the south. >> You got it. I'm glad you asked the

question too, because that is the untapped opportunity for a lot of LPs in this space, even if you're not a cultivator, which we are not, we're a pure play extractor. Everywhere from cultivation through to extracts only, we're all looking at that international opportunity if you have an eye on the global equation. And so we built our facility, we built our process, we built our portfolio with scalability in mind. So we've always had

the global supply chain in our horizons. This was accelerated this year actually. We did not intend to generate revenue off of export business or export partnerships, which we have this fiscal year. And we did that intentionally with a deliberate pivot in the fall. And that was because we experienced a strike here in BC. And the provincial government really owns the supply chain in each province. So in BC, the BCGEU, which

controls the BCLDB, our distributors within cannabis, went on strike for eight weeks. This was a huge hit for us as a company, because the biggest market for us in Canada is BC. So with that loss in revenue, frankly, over an eight-week period, we had to look at what else we were going to accelerate in our business strategy. And that really put the limelight on the export strategy. So

looking at our current inventory, our current product assortment, that is our hero assortment, which is soft gels, and they are produced in a Dell compliant facility, which means we can export to international jurisdictions where that licensing is compliant. So, we were able to do our first white label shipment of nearly a million soft gels to a commercial partner in Australia. That led to myself actually going on a

delegate's mission to Australia to do some research into the supply chain, establish more client contacts, and so now we have multiple client contracts underway in Australia for our soft gel assortment, which has been a really positive lift for not only our revenue this year, but also where we set ourselves up for next year. So, I'm feeling very hopeful for 2027, our fiscal year 2027 with a lot more focus

on the international equation. Our product assortment is ideally suited for international export because of shelf stability and because of approachability by the largest consumer segments. Soft gels are a very normalized format of consumption. So, for curious consumers, for cautious consumers, and even for competent consumers, it's very recognizable, it's very easy to consume, consistent in your efficacy because it's standardized, right? It's not variable like a crop, like flower or cannabis

flower would be. So, the consistency for a prescriber is there, the efficacy for a patient is there, and the ease of the supply chain side because of, you know, over 12 months or sorry, over 24 months stability for cannabis derivative products. So, all that to say, the maturity in the global supply chain has allowed us a really ease-filled entry, and we hope to see that continue to grow in 2027.

>> Yeah, it's interesting. It's fun to watch, not just you, but others in the Canadian landscape like take advantage, but also lead in other markets cuz that that was one of the promises of sort of legalizing nationally was that there would be the opportunities, and the opportunities are developing. I want to We talked about sort of the brands you have on the shelves, certainly, from a sort of consumer packaged good

perspective. We talked about a bit about sort of the international and some of the B2B stuff that you've been doing. Talk a little bit about balancing those two things because it's a lot of I don't know about the operational challenge, but it is different business models, right? There's the B2B and some licensing, and there's the B2C on the consumer side here in Canada. How do you balance that, and how do you think about

that going forward? Is it 50/50? Is it meant to be 50/50, or are there sort of opportunities you absolutely have to take on the B2B side that are like Just talk about sort of how you think about that in your boardroom at Next Leaf. >> You got it. With the B2B side of our business, so that's our bulk ingredient business. For anyone that's newer to Next Leaf, that's purchasing bulk

biomass and processing it into extracts at our facility. And what we've noticed over, you know, 8-plus years of operations is pricing compression. And it's no longer about buying, you know, the the what's the trim off the floor. It's no longer about turning garbage into gold. We're actually buying organically grown biomass at scale, you know, single-source supply from here in BC, like the best, most premium extract grade biomass you can be

processing. We buy that by the ton, by the acre, and process it by the ton. And so for us, that's a really big influx in the fall. We fill the vault, and then we can sell that through the year. That's not as stable as far as revenue goes. So it's a very dominant part of our business, a growing part of our business, non-excisable part of our business, so

that's a really healthy part for our bottom line. As many know, there's heavy excise on consumer packaged goods. So it gives us that variability and diversity in our revenue streams, gives us agility in our business model. But CPG and our consumer packaged goods, our branded products, that's the evergreen, all the time, that's what's giving us revenue month after month after month, and consistently allowing us to make projections, forecasts, and grow the

business. So, they're both crucial. They're both absolutely part of our DNA. the breadwinner right now is CPG for sure, and the Genesis story is really built off the bulk ingredients that fuels the product. So, it's all connected. but CPG is really something that we're quite proud of the revenue opportunity and potential. >> I didn't say this, people much smarter than me did, but when you're in

the cannabis industry, you're in the sort of watching government regulatory business. and I want to ask you sort of two questions on that front. One, the Canadian landscape has changed over the past 5 6 7 years. Like, what are some of the things that you're seeing on the sort of policy regulatory front that I either make you anxious and make you excited about what is ahead in

Canada? And then the sort of second part is, how closely do you follow what's happening like in the US, right? Cuz we've talked about sort of Australia. Like, it is there a world in which there's opportunity in the US for Canadian companies who are positioned as you are with like IP, unbelievable capacity, doing it for a long time. Like, do you sort of weigh that as well? So, sort of two

regulatory questions. One in Canada, and one sort of more broadly to other places. How busy are you looking at sort of what's happening in in either Congress or sort of other places? Yeah, both both very nuanced. So, if I forget to address one >> No, I'll get back to you. Yeah, yeah. >> Get back on track, but here in our backyard in BC, I've had the privilege

of participating in some lobbying efforts with the BC government, and this is through the Cannabis Cultivators of BC. This is a collective of LPs around the province that have come together to voice our concerns with the provincial government, which is where we see more progress being able to take effect. And we've actually seen incremental momentum towards things like a national excise stamp. This is huge for industry. for anyone that doesn't

know the nuance, we have to apply an individual stamp per province onto product that's going to be sold into that province. It makes a logistical nightmare if you want to transfer inventory from province to province. This is necessary in the fact that we're still a fledgling industry. You don't always perfectly know what your forecast is going to look like and it doesn't always roll up exactly as you intended. So,

there's the need to reallocate inventory nationally. It is a huge burden for LPs to have to bring that inventory back in house, take off the excise stamp, put on a new one. So, it seems very simple, but this is part of red tape reduction the industry's been pushing for for quite a while. Here in BC, we recently, within the last year, had a ministry change. So, rather than being under the Ministry

of Finance or the Ministry of Public Health and Safety in different provinces, it falls under different jurisdictions. We are now part of the Ministry of Agriculture in BC. We are the number two contributor from a tax perspective to the provincial government, exceeded only by dairy. Dairy and then cannabis. So, we have our MP's ear. Lana Popham, who's the Minister of Agriculture, is actually literally my backyard MP here in

Saanich. And so, we were able to go for the first ever lobbying day, a group of four of us here at the BC Parliament, speak to MPs around the province, get their ear, help normalize and socialize what the industry contributes to GDP and jobs, and get their endorsement for a letter that goes towards the the federal government to get this national excise stamp. And Lana's been beating the drum with other

ministers nationally to get them all to sign this letter to roll up into the federal government. So, this is where I think we're actually going to see momentum and change is at the provincial level because that's where we're contributing the most towards GDP and jobs. So, this has been a huge momentum builder and a huge opportunity, but also gives me a sense of optimism for what we're able to actually move the needle

on here in Canada. You had a question about kind of how that feeds into, you know, larger jurisdictions such as the US. We keep a watchful eye. We've got opportunities for licensing all day long, whether that's brands or IP. So, that's certainly on the table, but the most likely opportunity for us to foray with a commercial partner of some kind in the US is if more of an international

conglomerate. So, if they have other parts to their business at other divisions to their business in international jurisdictions. So, it wouldn't just be an American play. It wouldn't just be to service the US market. It might be to have other connections on a global scale. So, we're not looking so insularly just at the US. We're looking at how does that fit into the global supply chain, which might be

a little bit more on hemp as an example, biomass as an example, or like I said, the IP side of things. So, that's that's where our formulations, API, and then IP and our process comes in. >> Well, there's never a dull moment. I don't think over the past 6 years that I've known you there's been like a month or day or a week that goes by you're

like, "Well, this is now stable. This is great. Everything's great." But it But I think that is the unique part of the industry is that it is super dynamic and that there are companies with strong foundations putting products into the world, putting IP into the world like you that make it very exciting because they're able to adjust, pivot, take advantage of new opportunities like we talked about.

so, I appreciate the work that you and the team there does and look forward to connecting with you again and it won't be 6 years from now till the next time we connect. >> let's make sure of that. I think I'll have way too much to share if we wait another 6 years. So, thanks for the time, Jay. >> We appreciate it. Thanks so much. Thank you again to the Canadian

Securities Exchange and that was Emma Andrews. She is the CEO of Next Leaf Solutions, trading under OILS, and I am J Rosenthal from Cultivated. You can find everything we do at cultivated.news.

More CSE Listed Issuer Updates

See them all

Critical One Energy (CSE:CRTL)The Race for AntimonyNov 5, 2026
Hillcrest Energy (CSE:HEAT)Powering the Future with 99.7% EfficiencyOct 21, 2026
Nerds On Site (CSE:NERD)Profitability, Expansion & AISep 16, 2026
Purecore Metals (CSE:PURE)Uranium, Copper & Rising Power DemandSep 15, 2026